Real-time enrollment status for this nf1 mutation clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:01 AM UTC
| NCT Number | NCT06961565 |
| Recruiting Status | Recruiting |
| Condition | NF1 Mutation |
| Phase | PHASE1 |
| Target Enrollment | 56 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Pasithea Therapeutics Corp. |
| Last Updated on CT.gov | December 4, 2025 (Dec 4, 2025) |
As of July 17, 2026: Clinical trial NCT06961565 is currently recruiting participants. This phase1 study for nf1 mutation is actively seeking new participants at 1 location across the United States. The study is sponsored by Pasithea Therapeutics Corp.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06961565 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06961565 was last updated Dec 4, 2025 (December 4, 2025). HelloStudys verifies this status automatically.